MedPath

Disulfiram for Cocaine-Alcohol Abuse - 3

Phase 2
Completed
Conditions
Cocaine-Related Disorders
Alcohol-Related Disorders
Registration Number
NCT00000278
Lead Sponsor
Yale University
Brief Summary

The purpose of this study is to evaluate disulfiram for cocaine-alcohol abuse.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cocaine effects
Side effects
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

VA Connecticut Healthcare System

🇺🇸

New Haven, Connecticut, United States

VA Connecticut Healthcare System
🇺🇸New Haven, Connecticut, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.